Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9748226rdf:typepubmed:Citationlld:pubmed
pubmed-article:9748226lifeskim:mentionsumls-concept:C0002520lld:lifeskim
pubmed-article:9748226lifeskim:mentionsumls-concept:C0003593lld:lifeskim
pubmed-article:9748226lifeskim:mentionsumls-concept:C0207079lld:lifeskim
pubmed-article:9748226lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:9748226lifeskim:mentionsumls-concept:C1511545lld:lifeskim
pubmed-article:9748226pubmed:issue40lld:pubmed
pubmed-article:9748226pubmed:dateCreated1998-11-12lld:pubmed
pubmed-article:9748226pubmed:abstractTextSeveral studies have demonstrated protein-protein interactions between microsomal triglyceride transfer protein (MTP) and apolipoprotein B (apoB). However, the binding sites involved in these interactions have not been elucidated. To identify an MTP binding site in apoB, we have expressed several apoB sequences as fusion proteins with the eight-amino acid FLAG peptide. The chimeras were transiently expressed in COS cells, and conditioned media were used to study the binding of these sequences to either immobilized or soluble MTP. A polypeptide containing amino acids 270-570 (B:270-570), but not 1-300, bound to MTP. AGI-S17, an antagonist of apoB-MTP binding, inhibited the binding of B:270-570 to MTP but not to M2, a monoclonal antibody that recognizes the FLAG peptide. These data indicated that B:270-570 contains an MTP binding site. Next, sequences within 270-570 were subjected to C-terminal truncations at natural proline residues. B:270-509 bound less efficiently than B:270-570, whereas, B:270-430 and other shorter chimeras did not bind to MTP. Furthermore, truncations at amino acids 502 and 509 decreased MTP binding by 73 and 42%, respectively. These data indicate that B:430-570 in the alpha1-globular domain of apoB plays a crucial role in MTP binding and presumably in the initiation and maturation of apoB-containing lipoproteins.lld:pubmed
pubmed-article:9748226pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:languageenglld:pubmed
pubmed-article:9748226pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:citationSubsetIMlld:pubmed
pubmed-article:9748226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9748226pubmed:statusMEDLINElld:pubmed
pubmed-article:9748226pubmed:monthOctlld:pubmed
pubmed-article:9748226pubmed:issn0021-9258lld:pubmed
pubmed-article:9748226pubmed:authorpubmed-author:NayakNNlld:pubmed
pubmed-article:9748226pubmed:authorpubmed-author:HussainM MMMlld:pubmed
pubmed-article:9748226pubmed:authorpubmed-author:ShelnessG SGSlld:pubmed
pubmed-article:9748226pubmed:authorpubmed-author:BakillahAAlld:pubmed
pubmed-article:9748226pubmed:issnTypePrintlld:pubmed
pubmed-article:9748226pubmed:day2lld:pubmed
pubmed-article:9748226pubmed:volume273lld:pubmed
pubmed-article:9748226pubmed:ownerNLMlld:pubmed
pubmed-article:9748226pubmed:authorsCompleteYlld:pubmed
pubmed-article:9748226pubmed:pagination25612-5lld:pubmed
pubmed-article:9748226pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:meshHeadingpubmed-meshheading:9748226-...lld:pubmed
pubmed-article:9748226pubmed:year1998lld:pubmed
pubmed-article:9748226pubmed:articleTitleAmino acids 430-570 in apolipoprotein B are critical for its binding to microsomal triglyceride transfer protein.lld:pubmed
pubmed-article:9748226pubmed:affiliationDepartments of Pathology and Biochemistry, Allegheny University of the Health Sciences, MCP-Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129, USA. Hussaim@wpo.auhs.edulld:pubmed
pubmed-article:9748226pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9748226pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9748226pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9748226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9748226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9748226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9748226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9748226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9748226lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9748226lld:pubmed